Literature DB >> 24238303

The association between PFOA, PFOS and serum lipid levels in adolescents.

Sarah Dee Geiger1, Jie Xiao2, Alan Ducatman3, Stephanie Frisbee4, Kim Innes5, Anoop Shankar5.   

Abstract

INTRODUCTION: Dyslipidemia in children is associated with accelerated atherosclerosis and earlier cardiovascular disease development. Environmental exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have been shown to be associated with dyslipidemia in adults. However, there are few general population studies examining this association in children or adolescents. In this context, we examined the association between serum PFOA and PFOS levels and dyslipidemia in a nationally representative sample of US adolescents.
METHODS: A cross-sectional study was performed on 815 participants ⩽18 years of age from the National Health and Nutrition Examination Survey 1999-2008. The main outcome was dyslipidemia, defined as total cholesterol >170 mg/dL, low-density lipoprotein cholesterol (LDL-C) >110 mg/dL, high-density lipoprotein cholesterol (HDL-C) <40 mg/dL or triglycerides >150 mg/dL.
RESULTS: We found that serum PFOA and PFOS were positively associated with high total cholesterol and LDL-C, independent of age, sex, race-ethnicity, body mass index, annual household income, physical activity and serum cotinine levels. Compared to subjects in quartile 1 (referent), the multivariable-adjusted odds ratio (95% confidence interval) for high total cholesterol among children in quartile 4 was 1.16 (1.05-2.12) for PFOA and 1.53 (1.11-1.64) for PFOS. PFOA and PFOS were not significantly associated with abnormal HDL-C and triglyceride levels. DISCUSSION: Our findings indicate that serum PFOA and PFOS are significantly associated with dyslipidemia in adolescents, even at the lower "background" exposure levels of the US general population.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Lipids; PFC; Perfluoroalkyl chemicals; Perfluorooctane sulfonate; Perfluorooctanoic acid

Mesh:

Substances:

Year:  2013        PMID: 24238303     DOI: 10.1016/j.chemosphere.2013.10.005

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  45 in total

1.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

2.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

3.  Exposure to perfluorinated compounds: in vitro study on thyroid cells.

Authors:  Francesca Coperchini; Patrizia Pignatti; Serena Lacerenza; Sara Negri; Riccardo Sideri; Claudia Testoni; Luca de Martinis; Danilo Cottica; Flavia Magri; Marcello Imbriani; Mario Rotondi; Luca Chiovato
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-04       Impact factor: 4.223

4.  The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

Authors:  Kevin M Beggs; Steven R McGreal; Alex McCarthy; Sumedha Gunewardena; Jed N Lampe; Christoper Lau; Udayan Apte
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-03       Impact factor: 4.219

5.  Serum perfluoroalkyl substances in children exposed to the world trade center disaster.

Authors:  Leonardo Trasande; Tony T Koshy; Joseph Gilbert; Lauren K Burdine; Teresa M Attina; Akhgar Ghassabian; Masato Honda; Michael Marmor; Dinh Binh Chu; Xiaoxia Han; Yongzhao Shao; Kurunthachalam Kannan
Journal:  Environ Res       Date:  2017-01-16       Impact factor: 6.498

6.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.

Authors:  John Bassler; Alan Ducatman; Meenal Elliott; Sijin Wen; Banrida Wahlang; John Barnett; Matthew C Cave
Journal:  Environ Pollut       Date:  2019-01-18       Impact factor: 8.071

7.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

8.  Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.

Authors:  Ana M Mora; Abby F Fleisch; Sheryl L Rifas-Shiman; Jennifer A Woo Baidal; Larissa Pardo; Thomas F Webster; Antonia M Calafat; Xiaoyun Ye; Emily Oken; Sharon K Sagiv
Journal:  Environ Int       Date:  2017-11-20       Impact factor: 9.621

9.  Photochemical defluorination of aqueous perfluorooctanoic acid (PFOA) by Fe(0)/GAC micro-electrolysis and VUV-Fenton photolysis.

Authors:  Li-Hong Zhang; Jian-Hua Cheng; Xia You; Xiao-Yan Liang; Yong-You Hu
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-31       Impact factor: 4.223

10.  Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group.

Authors:  Tony T Koshy; Teresa M Attina; Akhgar Ghassabian; Joseph Gilbert; Lauren K Burdine; Michael Marmor; Masato Honda; Dinh Binh Chu; Xiaoxia Han; Yongzhao Shao; Kurunthachalam Kannan; Elaine M Urbina; Leonardo Trasande
Journal:  Environ Int       Date:  2017-09-08       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.